Literature DB >> 8844489

Severe acute hepatitis A associated with acute pure red cell aplasia.

S Tomida1, Y Matsuzaki, M Nishi, T Ikegami, T Chiba, M Abei, N Tanaka, T Osuga, Y Sato, T Abe.   

Abstract

A rare case of severe acute hepatitis A complicated by pure red cell aplasia (PRCA) is reported. A 60-year-old man with jaundice and hepatomegaly was diagnosed as having acute hepatitis A by positive IgM anti-hepatitis A antibody (anti-HAV). Severe anemia rapidly developed 3 weeks after admission, and the patient was diagnosed with PRCA by both bone marrow smears and erythrocyte survival study. The anemia was transient and bone marrow recovered within 1 week. However, concomitant with bone marrow recovery, the hepatitis worsened. He became drowsy and disoriented and severe jaundice, ascites, prolonged prothrombin time, increased transaminase levels, and abnormal electroencephalogram (EEG) were exhibited. Plasma exchange transfusion and glucagon-insulin (GI) therapy improved the consciousness level, but bilirubin, transaminase levels, and IgM anti-HAV titer remained high. Intravenous administration of lipophilized prostaglandin E1 (lipo-PGE1) was added to the GI therapy. Bilirubin and transaminase levels were normalized in the 8th week after the initiation of this combination therapy (17 weeks after admission). The combined use of lipo-PGE1 with plasma exchange and GI therapy appeared to be useful for the prolonged severe hepatitis in this patient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844489     DOI: 10.1007/bf02355068

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  17 in total

1.  Transient red blood cell aplasia in association with viral hepatitis. Occurrence four years apart in siblings.

Authors:  D A Sears; J N George; M S Gold
Journal:  Arch Intern Med       Date:  1975-12

2.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

3.  [Regeneration of the cirrhotic remnant liver after partial hepatectomy, especially the relationship between insulin receptors and hepatic regeneration].

Authors:  H Morioka
Journal:  Nihon Geka Hokan       Date:  1986-05-01

4.  The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model.

Authors:  Y Mizoguchi; H Tsutsui; K Miyajima; Y Sakagami; S Seki; K Kobayashi; S Yamamoto; S Morisawa
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

5.  Megaloblastic anemia associated with erythroid hypoplasia.

Authors:  J F Pezzimenti; J Lindenbaum
Journal:  Am J Med       Date:  1972-12       Impact factor: 4.965

6.  [A case of pure red cell aplasia following hepatitis A].

Authors:  J Tomiyama; H Kudou; Y Adachi; K Kinugasa; T Hanada
Journal:  Rinsho Ketsueki       Date:  1987-12

7.  Identification of virus components in circulating immune complexes isolated during hepatitis A virus infection.

Authors:  H S Margolis; O V Nainan
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

8.  Circulating immune complexes in patients with fulminant hepatic failure.

Authors:  J Canalese; R J Wyke; D Vergani; A L Eddleston; R Williams
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

9.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Transient pure red-cell aplasia: cell-mediated suppression of erythropoiesis associated with hepatitis.

Authors:  H A Wilson; G D McLaren; H J Dworken; K Tebbi
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

View more
  4 in total

1.  Protective effects of prostaglandin E1 on hepatocytes.

Authors:  Xian-Ling Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C.

Authors:  Cheng-Shyong Chang; Sheng-Lei Yan; Hsuan-Yu Lin; Fu-Lien Yu; Chien-Yu Tsai
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

3.  Pure red cell aplasia in a three-months-old infant possibly secondary to cytomegalo virus infection.

Authors:  Devki Nandan; Afsana Jahan; Vivek Dewan; Sarman Singh; Gurdeep Buxi
Journal:  Indian J Hematol Blood Transfus       Date:  2013-01-12       Impact factor: 0.900

4.  Pure red cell aplasia caused by acute hepatitis a.

Authors:  Tae Heon Lee; Suk Joong Oh; Soojung Hong; Kyu Bek Lee; Hyosoon Park; Hee-Yeon Woo
Journal:  Chonnam Med J       Date:  2011-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.